Related Experiment Videos
Simvastatin has deleterious effects on human first trimester placental explants
I Kenis1, S Tartakover-Matalon, N Cherepnin
1Oncogenetic Laboratory, Department of Internal Medicine A, Sapir Medical Center, Kfar-Saba, Israel.
Human Reproduction (Oxford, England)
|June 17, 2005
Summary
Simvastatin negatively impacts first-trimester human placental cells. This cholesterol-lowering drug, simvastatin, inhibits trophoblast migration and proliferation while increasing apoptosis and reducing progesterone secretion.
Area of Science:
- Reproductive biology
- Pharmacology
- Cell biology
Background:
- Statins, inhibitors of HMG-CoA reductase, are used for hypercholesterolemia but have shown teratogenic effects in animal models.
- Contraindicated in pregnancy due to potential risks, but human data on inadvertent exposure is conflicting.
- Investigated simvastatin's effects on an in vitro human placental model.
Purpose of the Study:
- To investigate the effects of simvastatin on human first-trimester placental explants in vitro.
- To assess simvastatin's impact on trophoblast cell migration, proliferation, and apoptosis.
- To evaluate simvastatin's effect on placental hormone secretion.
Main Methods:
- Human first-trimester placental explants cultured on matrigel were exposed to simvastatin.
- Extravillous trophoblast migration was assessed visually.
- Proliferation and apoptosis were evaluated using immunohistochemistry (Ki67 and activated caspase-3).
- Hormone levels, including progesterone, were measured.
Main Results:
- Simvastatin significantly inhibited extravillous trophoblast cell migration (P < 0.05).
- It reduced proliferative events within placental villi by 50% (P < 0.05) and increased cytotrophoblast apoptosis.
- Progesterone secretion from placental explants was significantly decreased (P < 0.01).
Conclusions:
- Simvastatin exerts adverse effects on human first-trimester placental trophoblast cells.
- These findings suggest potential risks associated with simvastatin exposure during early pregnancy.
- Further research is warranted to fully understand the implications for pregnancy outcomes.